Filing Details
- Accession Number:
- 0001140361-12-024089
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-05-09 19:52:02
- Reporting Period:
- 2012-04-02
- Filing Date:
- 2012-05-09
- Accepted Time:
- 2012-05-09 18:52:02
- Original Submission Date:
- 2012-04-04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070698 | Raptor Pharmaceutical Corp | RPTP | Pharmaceutical Preparations (2834) | 860883978 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235470 | M Christopher Starr | C/O Raptor Pharmaceutical Corp. 9 Commercial Blvd., Suite 200 Novato CA 94949 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-02 | 10,085 | $2.83 | 709,455 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-04-02 | 10,085 | $6.72 | 699,370 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock options (right to buy) | Disposition | 2012-04-02 | 10,085 | $0.00 | 10,085 | $2.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,072,588 | 2006-11-26 | 2016-05-26 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 9, 2012.
- Original option grant vests 6/36ths on May 26, 2006 and 1/36th per month thereafter.
- This Form 4/A corrects the Amount of Securities Beneficially Owned (reference the original Form 4 - Table I Item 5).
- This transaction was executed in multiple trades at prices ranging from $6.66 to $6.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This Form 4/A corrects the Number of Derivative Securities Beneficially Owned (reference the original Form 4 - Table II Item 9).
Billionaire Hedge Funds
